1. Home
  2. DYN vs VSCO Comparison

DYN vs VSCO Comparison

Compare DYN & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • VSCO
  • Stock Information
  • Founded
  • DYN 1984
  • VSCO 1977
  • Country
  • DYN United States
  • VSCO United States
  • Employees
  • DYN N/A
  • VSCO N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • VSCO Clothing/Shoe/Accessory Stores
  • Sector
  • DYN Health Care
  • VSCO Consumer Discretionary
  • Exchange
  • DYN Nasdaq
  • VSCO Nasdaq
  • Market Cap
  • DYN 1.9B
  • VSCO 2.1B
  • IPO Year
  • DYN 2020
  • VSCO N/A
  • Fundamental
  • Price
  • DYN $22.58
  • VSCO $35.25
  • Analyst Decision
  • DYN Strong Buy
  • VSCO Hold
  • Analyst Count
  • DYN 14
  • VSCO 12
  • Target Price
  • DYN $34.93
  • VSCO $29.50
  • AVG Volume (30 Days)
  • DYN 3.0M
  • VSCO 2.2M
  • Earning Date
  • DYN 10-28-2025
  • VSCO 12-04-2025
  • Dividend Yield
  • DYN N/A
  • VSCO N/A
  • EPS Growth
  • DYN N/A
  • VSCO 6.76
  • EPS
  • DYN N/A
  • VSCO 1.86
  • Revenue
  • DYN N/A
  • VSCO $6,265,000,000.00
  • Revenue This Year
  • DYN N/A
  • VSCO $4.70
  • Revenue Next Year
  • DYN N/A
  • VSCO $2.67
  • P/E Ratio
  • DYN N/A
  • VSCO $18.99
  • Revenue Growth
  • DYN N/A
  • VSCO 2.29
  • 52 Week Low
  • DYN $6.36
  • VSCO $13.76
  • 52 Week High
  • DYN $35.68
  • VSCO $48.73
  • Technical
  • Relative Strength Index (RSI)
  • DYN 74.06
  • VSCO 67.88
  • Support Level
  • DYN $23.05
  • VSCO $30.65
  • Resistance Level
  • DYN $25.00
  • VSCO $38.05
  • Average True Range (ATR)
  • DYN 1.02
  • VSCO 1.53
  • MACD
  • DYN 0.72
  • VSCO 0.26
  • Stochastic Oscillator
  • DYN 78.24
  • VSCO 71.72

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About VSCO Victorias Secret & Co.

Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.

Share on Social Networks: